Cargando…
盐酸阿那格雷胶囊治疗原发性血小板增多症的有效性和安全性——多中心、随机对照临床研究
OBJECTIVE: To evaluate the efficacy and safety of anagrelide in essential thrombocythemia (ET). METHODS: Patients who diagnosed as ET according to the World Health Organization classification were enrolled. Each patient was assigned to take anagrelide hydrochloride capsule or hydroxyurea tablet by r...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342634/ https://www.ncbi.nlm.nih.gov/pubmed/26304075 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.07.004 |
Ejemplares similares
-
重组人血小板生成素用于原发免疫性血小板减少症维持治疗的有效性和安全性——多中心临床研究
Publicado: (2017) -
培美曲塞及吉西他滨分别联合顺铂治疗初治晚期非小细胞肺癌安全性和有效性的随机对照研究
Publicado: (2012) -
盐酸恩沙替尼胶囊的药理与临床评价
Publicado: (2020) -
IAC方案治疗复发/难治急性髓系白血病疗效与安全性分析:前瞻性随机对照研究
Publicado: (2022) -
原发性血小板增多症研究的新进展
Publicado: (2015)